The observation that one patient (USA3-II:2) with a heterozygous variant and later onset peripheral neuropathy phenotype may suggest potential dominant-negative impacts from variants in NEMF. Future work will address potential modifiers and determine if this allele could dominantly cause disease in mouse models. This evidence concerns the gene NEMF and peripheral neuropathy.